Erdheim-Chester disease (ECD) is a rare inflammatory neoplasm in the non-Langerhans cell histiocytosis group. BRAF V600E mutation is detected in 50-60% of patients and offers targeted therapy...
Age Range
40-70
Peak Age
55
Gender
Male predominant
Prevalence
Rare